Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioanalytical Methods for New Psychoactive Substances
Lea Wagmann, Hans H. Maurer
Handbook of experimental pharmacology (2018), pp. 413-439
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices
Silvia Graziano, Luca Anzillotti, Giulio Mannocchi, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 163, pp. 170-179
Closed Access | Times Cited: 85
The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
Marthe M. Vandeputte, Alex J. Krotulski, Donna M Papsun, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 2, pp. 115-121
Open Access | Times Cited: 60
Chemical classification of new psychoactive substances (NPS)
Félix Zapata, José Manuel Matey, Gemma Montalvo, et al.
Microchemical Journal (2020) Vol. 163, pp. 105877-105877
Closed Access | Times Cited: 52
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases
Giulio Mannocchi, Annagiulia Di Trana, Anastasio Tini, et al.
Analytical and Bioanalytical Chemistry (2020) Vol. 412, Iss. 21, pp. 5125-5145
Open Access | Times Cited: 49
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings—A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae
Lea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 44
A Comprehensive HPLC–MS-MS Screening Method for 77 New Psychoactive Substances, 24 Classic Drugs and 18 Related Metabolites in Blood, Urine and Oral Fluid
Annagiulia Di Trana, Giulio Mannocchi, Filippo Pirani, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 8, pp. 769-783
Open Access | Times Cited: 42
Use of statistical design of experiments (DoE) in Forensic Analysis: A tailored review
Vítor Luiz Caleffo Piva Bigão, Bruno Ruiz Brandão da Costa, Jonas Joaquim Mangabeira da Silva, et al.
Forensic Chemistry (2024) Vol. 37, pp. 100554-100554
Closed Access | Times Cited: 6
Current Status of Clinical Application of Point-of-Care Testing
Hyung‐Doo Park
Archives of Pathology & Laboratory Medicine (2020) Vol. 145, Iss. 2, pp. 168-175
Open Access | Times Cited: 37
Hyphenated high-resolution mass spectrometry—the “all-in-one” device in analytical toxicology?
Hans H. Maurer
Analytical and Bioanalytical Chemistry (2020) Vol. 413, Iss. 9, pp. 2303-2309
Open Access | Times Cited: 37
Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology
Hans H. Maurer
Therapeutic Drug Monitoring (2018) Vol. 40, Iss. 4, pp. 389-393
Closed Access | Times Cited: 38
New Psychoactive Substances
Hans H. Maurer, Simon D. Brandt
Handbook of experimental pharmacology (2018)
Closed Access | Times Cited: 37
Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
Katharina Elisabeth Grafinger, Matthias E. Liechti, Evangelia Liakoni
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 3, pp. 429-436
Open Access | Times Cited: 34
Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine
Tanja M. Gampfer, Lea Wagmann, Yu Mi Park, et al.
Archives of Toxicology (2020) Vol. 94, Iss. 6, pp. 2009-2025
Open Access | Times Cited: 30
Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview
Frank T. Peters, Daniela Wissenbach
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 8, pp. 487-500
Closed Access | Times Cited: 10
A cohort-based assessment of drug use trends during the COVID-19 pandemic: relationship with mood and sociodemographic factors in Brazil
Núbia Heidrich, Maurício Schüler Nin, Felipe Borges Almeida, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Amphetamine-type stimulants and phenethylamines in the landscape of new psychoactive substances
Aline Thaís Bruni, Caio Henrique Pinke Rodrigues, Lívia Salviano Mariotto, et al.
Comprehensive analytical chemistry (2025)
Closed Access
Untargeted Mass Spectrometry Applications for Clinical Toxicology
Adina Badea
Clinics in Laboratory Medicine (2025) Vol. 45, Iss. 2, pp. 177-186
Closed Access
A New Multi-Analyte LC–MS-MS Screening Method for the Detection of 120 NPSs and 49 Drugs in Hair
Jolanda Rubicondo, Lapo Scuffi, Laura Pietrosemoli, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 9, pp. e262-e273
Open Access | Times Cited: 15
Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products
Lea Wagmann, Sascha K. Manier, Thomas P. Bambauer, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 6, pp. 549-558
Open Access | Times Cited: 22
Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone
Lea Wagmann, Sascha K. Manier, Niels Eckstein, et al.
Forensic Toxicology (2019) Vol. 38, Iss. 1, pp. 59-69
Open Access | Times Cited: 22
Pitfalls in drug testing by hyphenated low‐ and high‐resolution mass spectrometry
Hans H. Maurer
Drug Testing and Analysis (2019) Vol. 12, Iss. 2, pp. 172-179
Open Access | Times Cited: 21
Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
Adrian A Deen, Hugh Claridge, Richard D Treble, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 11, pp. 1315-1323
Open Access | Times Cited: 17
Interactions of phenethylamine‐derived psychoactive substances of the 2C‐series with human monoamine oxidases
Lea Wagmann, Simon D. Brandt, Alexander Stratford, et al.
Drug Testing and Analysis (2018) Vol. 11, Iss. 2, pp. 318-324
Open Access | Times Cited: 20
Simultaneous LC-MS/MS screening for multiple phenethylamine-type conventional drugs and new psychoactive substances in urine
Shu-Yu Fan, Chi-Zong Zang, Po-Han Shih, et al.
Forensic Science International (2021) Vol. 325, pp. 110884-110884
Closed Access | Times Cited: 16
Drug testing in the era of new psychoactive substances
Roy Gerona, Deborah French
Advances in clinical chemistry (2022), pp. 217-263
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top